IP Library Granted Patent US 8,016,810
Granted Patent B2
US 8,016,810 · App. 10/561,933 · Granted Sep 13, 2011

Transdermal delivery system for cosmetic agents

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,016,810
App. No.
10/561,933
Granted
Sep 13, 2011
Kind
B2
Abstract

An intradermal or transdermal delivery system for topical administration of cosmetic agents, particularly water-soluble, poorly water-soluble, or water-insoluble cosmetic agents, in conjunction with an apparatus that generates micro-channels in the skin of a subject, is useful in treating skin conditions such as cellulite, hyper-pigmentation, skin aging, and acne.

Claims (16)

1. A method for treating a skin condition in a subject comprising the steps of:

(i) pretreating skin by generating a plurality of micro-channels in an area of skin of a subject suffering from a skin condition by an apparatus which comprises:

a. an electrode cartridge comprising a plurality of electrodes to be oriented generally perpendicularly to the skin with electrode ends in the vicinity of the skin; and

b. a main unit comprising a control unit which is adapted to apply electrical energy between two or more electrodes when the electrodes are in vicinity of the skin, typically generating current flow that passes between the electrodes and through the stratum corneum, enabling ablation of stratum corneum in the area beneath the electrodes, thereby generating in the stratum corneum a plurality of micro-channels having a diameter of about 10 microns to about 100 microns and a depth of about 20 microns to about 300 microns; and

(ii) topically applying to the pre-treated skin and without the application of mechanical or physical means that increases the permeation of the composition through the skin a dermatologically effective amount of a cosmetic or dermatological composition comprising at least one water-soluble, poorly water-soluble or water-insoluble cosmetic agent and a cosmetically or dermatologically acceptable carrier to the area of the skin in which the micro-channels are present so as to improve the skin condition of said subject, the cosmetic or dermatological composition is devoid of permeation enhancers,

wherein the electrode cartridge is configured and dimensioned for removable attachment to the main unit wherein the cartridge is removably attached to the main unit for applying the electrical energy and thereafter can be detached.

2. The method according to claim 1 , wherein the cosmetic agent is selected from the group consisting of xanthines, retinoids, α-hydroxy acids, β-hydroxy acids, α-2 adrenergic inhibitors, β-adrenergic agonists, aromatase inhibitors, anti-estrogens, hydroquinone, ascorbic acid, kojic acid, corticosteroids, mucopolysaccharides, collagen, estrogens, isoflavonoids, cinnamic acid, benzoyl peroxide, tropolone, catechol, mercaptoamine, niacinamide, tocopherol, ferulic acid, azelaic acid, botulinum, urea, a derivative or salt thereof.

3. The method of claim 2 , wherein the xanthine is caffeine.

4. The method according to claim 2 , wherein the β-hydroxy acid is salicylic acid.

5. The method according to claim 2 , wherein the cosmetic agent is hydroquinone.

6. The system according to claim 1 , wherein the cosmetic or dermatological composition further comprises at least one component selected from the group consisting of surfactants, humectants, preservatives, antioxidants, powders, clarifying agents, coloring agents, opacifiers, thickeners, and perfumes, and the electrode cartridge is discarded after detachment from the main unit.

7. The method according to claim 1 , wherein the cosmetic or dermatological composition further comprising a pharmaceutical agent.

8. The method according to claim 7 , wherein the pharmaceutical agent is an antibacterial agent.

9. The method according to claim 1 , wherein the cosmetic or dermatological composition is formulated in a form selected from the group consisting of anhydrous compositions, aqueous solutions, aqueous suspensions, oil-in-water emulsions, water-in-oil emulsions, oily droplets in aqueous solutions, micelles, liposomes, ethosomes, and aqueous suspensions of nanoparticles.

10. The method according to claim 1 , wherein the cosmetic or dermatological composition is in a form selected from the group consisting of lotions, creams, ointments, gels, pastes, sprays, foams, sticks, and skin patches.

11. The method according to claim 1 , wherein the skin condition is selected from cellulite, acne vulgaris, acne cystic, skin aging, skin wrinkles, hyperpigmentation, keratosis, skin blemish, dandruff, warts, photodamaged skin, chronic dermatoses, dermatitis, dryness, ichthyosis, viral infections, fungal infections, and bacterial skin infections.

Assignments (4)
RELEASE (REEL 043925 / FRAME 0001) Recorded Apr 4, 2022
From: ING CAPITAL LLC
To: SYNERON MEDICAL LTD.; CANDELA CORPORATION; PRIMAEVA CORPORATION
Reel/Frame 059593/0131 →
SECURITY AGREEMENT Recorded Sep 20, 2017
From: SYNERON MEDICAL LTD.; CANDELA CORPORATION; PRIMAEVA CORPORATION
To: ING CAPITAL LLC, AS COLLATERAL AGENT
Reel/Frame 043925/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2012
From: TRANSPHARMA MEDICAL LTD
To: SYNERON MEDICAL LTD
Reel/Frame 028108/0010 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 17, 2008
From: LEVIN, GALIT; SACKS, HAGIT
To: TRANSPHARMA MEDICAL LTD.
Reel/Frame 021107/0224 →